ArticleAdvanced healthcare materials2025
Enzyme-Instructed Self-Assembly Reprograms Fatty Acid Metabolism for Cancer Therapeutics.
Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Sequence-Defined Short Peptide-Derived Coacervate Vesicles for Targeted Therapeutics.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Enzyme-Instructed Self-Assembly for Cellular Supramolecular Chemistry.Chemistry, an Asian journal · 2025Review
- Self-Assembled Nanoparticles: Overcoming Limitations of Conventional Nanomedicines for Enhanced Tumor Therapy.International journal of nanomedicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Enzyme-instructed self-assembly (EISA) is actively explored as a promising therapeutic approach for cancer treatment. However, the metabolic response of cancer cells to EISA remains under-studied. Here, by stimulated Raman scattering (SRS) imaging in C─H, fingerprint, and silent windows, it is found that the formation of peptide assemblies within and around cancer cells significantly enhances both lipids catabolism and fatty acids (FAs) uptake. It is further found that the increased uptake of FAs aids the resistance of cancer cells under EISA treatment, likely to cope with the stress induced by the peptide assemblies. Combining EISA with FAs uptake inhibition leads to enhanced cancer suppression compared to EISA alone, while additional FAs supplementation rescue cancer cells from EISA treatment, both in vitro and in 3D-culture spheroid models. These findings shed new light on the impact of EISA on the metabolic activities of cancer cells and suggest a new approach for improved cancer therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.